Carnosine supplementation in AD might seem reasonable because mice with AD and mice with knockout of beta secretase 1, which is a key enzyme in the clearance of β-amyloid, have reduced carnosine brain content [96]. The gene discussed is BACE1; the disease is Alzheimer disease.